Bhageria Industries Receives EDQM EU-GMP Attestation for Vapi Facility
Bhageria Industries Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 10:50 pm
Bhageria Industries Receives EDQM EU-GMP Attestation for Vapi Facility Bhageria Industries has received an Attestation of Good Manufacturing Practice inspection approval from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its manufacturing site at GIDC Phase IV, Vapi, Gujarat. Following an inspection carried out between 4th Feb'26 and 6th Feb'26, the attestation confirms compliance with European GMP requirements under Certificate of Suitability (CEP) No. 2024-138 framework for the manufacture of active pharmaceutical ingredient Dexamethasone.
Original exchange filing (PDF)
More announcements from Bhageria Industries Ltd
- Bhageria Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- Unaudited Financial Result ( Standalone & Consolidated) of Bhageria Industries Limited for Quarter & Half year ended 30, September, 2026. 路 29 Oct 2026
- Outcome of the Board Meeting oof Bhageria Industries Limited held on 28th October, 2026. 路 29 Oct 2026
- Announcement under Regulation 30 (LODR): Update 路 22 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 28 Oct 2026
- BHAGERIA INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 28 Oct 2026
- Bhageria Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve Bhageria Industries Limited .... 路 28 Oct 2026
- Announcement under Regulation 30, (2015)-Revised Credit Rating 路 07 Oct 2026
